QT
HRMY icon

Quantbot Technologies’s Harmony Biosciences HRMY Stock Holding History

Quantbot Technologies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$532K Sell
14,614
-67,037
-82% -$2.11M 0.02% 894
2026
Q1 		$2.29M Buy
81,651
+37,820
+86% +$1.24M 0.09% 335
2025
Q4 		$1.64M Buy
+43,831
New +$1.44M 0.05% 516
2025
Q3 		– Sell
-10,311
Closed -$326K – 1904
2025
Q2 		$326K Sell
10,311
-18,102
-64% -$582K 0.01% 1111
2025
Q1 		$943K Buy
28,413
+22,487
+379% +$806K 0.03% 702
2024
Q4 		$204K Buy
5,926
+4,073
+220% +$140K 0.01% 1049
2024
Q3 		$74.1K Buy
+1,853
New +$65.1K ﹤0.01% 1220
2024
Q2 		– Sell
-14,809
Closed -$497K – 1644
2024
Q1 		$497K Buy
14,809
+8,343
+129% +$268K 0.03% 745
2023
Q4 		$209K Buy
+6,466
New +$180K 0.01% 1001
2023
Q3 		– Sell
-4,718
Closed -$166K – 1726
2023
Q2 		$166K Buy
+4,718
New +$163K 0.01% 1026
2023
Q1 		– Sell
-3,417
Closed -$188K – 1764
2022
Q4 		$188K Sell
3,417
-635
-16% -$34.9K 0.01% 920
2022
Q3 		$179K Buy
4,052
+576
+17% +$28.1K 0.01% 923
2022
Q2 		$169K Sell
3,476
-6,951
-67% -$313K 0.02% 987
2022
Q1 		$507K Buy
10,427
+8,527
+449% +$348K 0.04% 564
2021
Q4 		$81K Buy
+1,900
New +$75.7K 0.01% 920

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's HRMY Position: Q2 2026 in Review

Quantbot Technologies reduced its Harmony Biosciences (HRMY) stake by 82% in Q2 2026, selling an estimated $2.11M and leaving 14,614 shares worth $532K. The position accounts for 0.02% of the portfolio, ranked #894.

Quantbot Technologies first reported a position in HRMY in Q4 2021 and has held it in 15 quarters since. The position peaked at $2.29M in Q1 2026. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Quantbot Technologies held 14,614 shares of Harmony Biosciences worth $532K as of Q2 2026.
  • Quantbot Technologies sold 67,037 Harmony Biosciences shares in Q2 2026, an estimated $2.11M.
  • Harmony Biosciences made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #894 holding.
  • Quantbot Technologies first reported a position in Harmony Biosciences in Q4 2021 and has held it in 15 quarters since.
  • Quantbot Technologies's Harmony Biosciences position peaked at $2.29M in Q1 2026.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.